Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
Enables unique vector and process optimizations for different molecules to increase the likelihood of high titer clonal cell lines.
Sapio Sciences and Zifo announce strategic partnership
Industry leaders to provide world-class lab informatics platform, services and support to life science customers
Bio-Rad adds rapid bispecific antibody prototyping and screening services to Pioneer Antibody Discovery Platform
New service enables identification of bispecific antibody candidates accelerating drug developmentHercules, Calif.
Kadans Science Partner commences work on new purpose-built wet lab facilities at Merlin Place, North Cambridge
New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys
Bio-Rad outlines its advances leveraging droplet digital PCR in biopharma and translational research sectors
Strategic Collaborations in Molecular Residual Disease Monitoring of Cancer and Product Launches in ddPCR Portfolio Advance Corporate Strategy in H1 2024
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
Appointment of experienced preclinical CRO specialist to support accelerated expansion into key global marketsCambridge, UK, 23 July 2024: Metrion Biosciences Ltd, the
Enterprise Therapeutics doses first person with Cystic Fibrosis in Phase 2 Trial for novel therapy ETD001
Trial aims to deliver clinical proof-of-concept and assess the safety profile of novel long acting ENaC inhibitor ETD001 ETD001, a CFTR
Lario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research
Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Parkinson's disease
Sapio Sciences launches Partner program to accelerate research and diagnostics
Baltimore, MD — Sapio Sciences, the science-awareTM lab informatics platform, announces the
Cellular Origins appoints Geoffrey Hodge as Non-Executive Director
Appointment brings additional significant strategic, technical and commercial experience to the Board
Closed Loop Medicine selected to join NVIDIA Inception
London, UK: Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug
Newcells Biotech appoints Emile Shaffu as Director of Sales
Key commercial appointment follows a series of executive team changes to support ongoing company expansion
H.E.L Group appoints Professor Yih-Shing Duh as Chief Scientific Advisor
Expert in battery testing further strengthens H.E.L’s expertise in thermal safety Professor Duh wi
Cellular Origins acquires ACTIA Platform IP to enhance automated cell therapy manufacturing
Autologous Cell Therapy Industrial Automation (ACTIA) strengthens technology and IP portfolio of Cellular Origins supporting ongoing development and expanding capabilities of Constellation platform
Bio-Rad launches ChemiDoc Go Imaging System
Compact system uses CMOS Digital Imaging and is compatible with chemiluminescence and fluorescence detection and stain-free technology
Bio-Rad launches Celselect Slides 2.0 to advance rare cell and circulating tumor cell enrichment for cancer research
New Celselect Slides™ Design Increases Efficiency of Circulating Tumor Cell Capture from Liquid Biopsy Samples for Enumeration and Downstream Applications
Sapio Sciences introduces Sapio GMP LIMS offering unmatched flexibility for unique manufacturing processes
Sapio Sciences announces key new capabilities to its highly flexible, no/low-code LIMS to support laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards
Bio-Rad extends range of anti-biotherapeutic antibodies to accelerate antibody drug development
Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials
Bio-Rad launches ddSEQ™ Single-Cell 3' RNA-Seq Kit for Single-Cell Gene Expression
ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Analysis Software Enable High-Quality and Affordable Single-Cell Transcription and Gene Expression to Support Molecular Biology, Oncology, and Drug Discovery Research
Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development
Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays
Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director
Brighton, UK: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory
Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker
Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance
Newcells Biotech strengthens executive and US team with key appointments
Dr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor New US commercial a